Session date: 
02/13/2019 - 12:10pm to 1:00pm

Aaron S. Mansfield, M.D.  
Professor of Oncology, Mayo Clinic
Principle Investigator of translational projects on the dynamics of the immune response to immunotherapy

Locations:

  • Geffen Auditorium (Live)
  • Broadcast to SMH Alfred M-459 and MA 17-64
  • Mayo Clinic Health System in Waycross (Video Conference)

Lunch available outside Geffen Auditorium and SMH Alfred M-459 on a first come, first serve basis


Learning Objectives:

  • Describe how immunotherapy has changed the treatment landscape for patients with lung cancer
  • Identify molecular subsets of lung cancer and how those affect response to immunotherapy
  • Assess molecular methods to select patients for treatment with immunotherapy

Financial Disclosure:

  • Consultant - Abbvie, Genentech
  • Grant/Research Support - Novartis, Verily
  • Honoraria - Abbvie, Genentech

Off Label/Investigational Uses:

  • None

 

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Presenter: 
Aaron S. Mansfield, M.D.
Where did the idea for the course originate?: 
Minnesota
Please login or register to take this course.
Where did the idea for the course originate?: 
Minnesota